January 11, 2023 The First 2023 Warning Letter Belongs to a CBD Company Takeaway - Remove COVID claims including on YouTube
January 4, 2023 Biomarker Claims Lead to Warning Letter Takeaway - Expect arterial health claims to be cited in the future
December 21, 2022 Website “About Us” Claims Cited in Warning Letter Takeaway - Discussing ingredient benefits is marketing
December 14, 2022 Saying “Thanks” on a Social Post Leads to Warning Letter Takeaway - Do not engage with customer “disease” testimonials
December 7, 2022 Tea Product Cited for Blood Sugar, Cholesterol & Cancer Claims Takeaway - Product claims must be compliant
November 30, 2022 FDA sends 7 Cardiovascular Disease Related Warning Letters Takeaway - Discussing cholesterol or LDL levels is a disease claim
November 23, 2022 FDA Issues Five CBD-Related Warning Letters Takeaway - CBD enforcement is top of mind for FDA
November 16, 2022 Product “Tags” With Disease Claims Elevate Risk Takeaway - Ingredient research can be considered a marketing claim
November 9, 2022 Supplement Labeling Errors lead to Warning Letter Takeaway - Common labeling errors can be avoided
November 2, 2022 Walmart & Amazon Issued Warning Letters for Adulterated Products & Disease Claims Takeaway - Distributors are responsible for the products they sell
October 26, 2022 Ayurvedic Product Company Receives Covid Warning Letter Takeaway - Discussing ingredient benefits is a marketing claim